Impact of Blood Culture Positivity Time on Clinical Management of Pediatric ICU Patients
NCT ID: NCT05507957
Last Updated: 2022-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2023-01-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Blood culture (BC) is considered the gold standard for sepsis etiological diagnosis , with good sensitivity ,but suffering usually of delay or even failure to detect microorganisms in patients already treated with antimicrobials and failure to identify pathogens other than bacteria or yeast (2, 3).
Time-to-positivity (TTP) of blood cultures is defined as the time from the start of incubation to a positive signal. Knowledge of the distribution of blood culture TTP is of clinical benefit in the re-evaluation of patients with a clinical syndrome consistent with infection. A low probability of bacteremia when blood cultures have remained negative after 24 hours (4). Positive episodes with TTP more than or equal 24 h are commonly optimally treated infections, catheter-related infections, or infections caused by slowly growing microorganisms such as Candida or anaerobic Gram-negative bacteria. Growth of multidrug-resistant Gram-negative bacilli is exceptional beyond 24 h. In current clinical practice, bacteremia is considered unlikely if blood cultures have been negative for 48-72 hours (5, 6). Most blood culture bottles turn positive in less than 4 days, shortening the duration of incubation appears the most relevant solution in order to free additional capacity(4).
Various disinfectants, such as povidone iodine (PVI), alcohol preparations, and chlorhexidine gluconate ethanol (CHG-ALC), are used for disinfection prior to blood culture sampling. Contamination rates of cultured blood samples vary according to the disinfectant used, sampling site, definition of contamination, and skill level of individuals performing the venipuncture.(7, 8)
In this study, Investigators assessed the real life clinical impact on septic ICU patients based on time of blood culture positivity time.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sepsis in ICU:Causes and Outcomes of Sepsis in Diabetics Versus Non Diabetics in Assiut University Hospital
NCT04015752
Sepsis in ICU:Causes and Outcomes in Diabetics and Non Diabetics
NCT05914480
Blood Indices of Systemic Inflammation in Critically Ill Patients With Abdominal Sepsis
NCT06095830
The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUO
NCT01410578
Assessment of Red Cell Distribution Width's Prognostic Ability in Septic Intensive Care Unit Patients
NCT06847451
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Evaluate the impact of blood culture positivity time in real -life clinical practice (patient management and reduction of ICU stay, as well as decreases in 30-days mortality.)
2. Investigates the probability of blood culture positivity after 24 hours.
3. evaluate if there was diagnostic value of TTP
4. Identify if there is difference in the blood culture contamination rate between uses of various type of disinfectant.
Sample Size Calculation: 120 septic patient in pediatric intensive care unit
Study tools:
The following will be done to all patients:
Data collection:
Clinical data (were retrieved from the medical records) :
* age and weight
* Date and time of culture collection
* pre-existing medical conditions (concomitant disease).
* Clinical parameters at presentation. The most likely source of bacteremia
* if start empirical antibiotic treatment before collection or not and its type, duration (concomitant antimicrobial therapy)
* volume of blood drawn in the bottles
* outcome data. Including change of antibiotic treatment and time to switch to directed therapy, length of ICU stay and 30-day mortality.
Microbiological data (were retrieved from the database of the Department of Medical Microbiology.) :
* date and time of bottle loading ( to know transportation time)
* date and time in which growth was first reported
* TTP(time to positivity of blood culture)
* Pathogen detected by blood culture
Blood culture sampling :
* collecting blood samples as soon as possible after the onset of clinical symptoms, ideally prior the administering antimicrobial therapy.
* Disinfection using povidone-iodine, alcohol preparation, or chlorhexidine gluconate ethanol (CHG-ALC ), so that each type was used on 40 patients
* collect 2 sets of blood culture bottles. blood culture was obtained either at one time or over a brief time period (e.g. within 1 hour) from multiple venipuncture sites.
* Blood for culture must be collected and dispensed aseptically with great care to avoid contaminating the specimen and culture medium
Blood culture handling procedures and laboratory techniques:
* Rapid transportation to microbiology unit.
* Rapid bottle loading in bioMerieux BacT/Alert Virtuo where it was incubated for 5 days
* Direct Gram stain was performed for all positive blood culture bottles.
* Followed by subculture onto solid agar media, including blood agar, chocolate agar \& MacConkey agar and sabaroud agar (Diagnostic Media products(DMP). Then identification of microorganisms and antibiotic susceptibility by Vitek 2.
* Direct reporting method to the pediatric intensive care unit
* The presence of one of the following microorganisms in a single BC bottle or Blood Culture set was considered as contaminant: coagulase-negative staphylococci (CoNS), with the exception of S. lugdunensis, Propionibacterium spp., Bacillus spp. other than B. anthracis, Corynebacterium spp. (diphtheroids), Aerococcus-like organisms, Micrococcus spp., viridans group streptococci other than S. pneumoniae, and Neisseria spp. other than N. gonorrhoeae or N. meningitidis. These microorganisms were considered as significant when other BC bottles collected 48h before were positive with the same microorganism, after reviewing of clinical data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
direct reporting of time to positivity of blood culture to ICU to know its effect to patients managment
-Disinfection using povidone-iodine, alcohol preparation or chlorhexidine gluconate ethanol (CHG-ALC ), so that each type was used on 40 patients
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undetermined fever ( ≥ 38°C) or hypothermia ( ≤ 36°C).
* Shock, chills, rigors
* Severe local infections (meningitis, endocarditis, pneumonia, pyelonephritis, intra-abdominal suppuration etc.) Multiple episodes of bacteremia per patient were allowed if the antimicrobial therapy for the previous episode had been completed and clinical and microbiological cure had been achieved
Exclusion Criteria
1 Day
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatma Salah EL-Dein Hosney
master of clincical patholofy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mohammed Z Abo krisha, professor
Role: PRINCIPAL_INVESTIGATOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assuit university
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
endnote
Related Links
Access external resources that provide additional context or updates about the study.
Seasonal variations in blood culture numbers and time to positivity and potential impact of reducing incubation periods
Time to positivity of blood cultures in patients with bloodstream infections: A useful prognostic tool
Neither Blood Culture Positivity nor Time to Positivity Is Associated With Mortality Among Patients Presenting With Severe Manifestations of Sepsis: The FABLED Cohort Study
Chlorhexidine alcohol versus povidone-iodine: The comparative study of skin disinfectants at the blood transfusion centers of Iran
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
fatma elnaggar
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.